Cheetah Medical Inc.
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 90/100
33.3%
2 terminated/withdrawn out of 6 trials
66.7%
-19.8% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
RESIPI for Reducing Perioperative Major Adverse Cardiac Events
Role: collaborator
Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis
Role: lead
Fluid Responsiveness Evaluation in Sepsis-associated Hypotension
Role: lead
Non-invasive Cardiac Output Monitor in Young Adults
Role: collaborator
Pre-emptive Hemodynamic Optimization of High Risk Patients Undergoing Elective Major Surgical Procedures
Role: collaborator
Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study
Role: collaborator
All 6 trials loaded